Literature DB >> 22395358

Long-term molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.

Endri Mauro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22395358      PMCID： PMC3496217          DOI： 10.2450/2012.0144-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

1.  Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.

Authors:  Dino Veneri; Cristina Tecchio; Giovanna De Matteis; Elisa Paviati; Marco Benati; Massimo Franchini; Giovanni Pizzolo
Journal:  Blood Transfus       Date:  2011-09-22       Impact factor: 3.443

Review 2.  Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

Authors:  Holger Rumpold; Gerald Webersinke
Journal:  Curr Cancer Drug Targets       Date:  2011-01       Impact factor: 3.428

3.  Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.

Authors:  Jorge E Cortes; Moshe Talpaz; Francis Giles; Susan O'Brien; Mary Beth Rios; Jianqin Shan; Guillermo Garcia-Manero; Stefan Faderl; Deborah A Thomas; William Wierda; Allessandra Ferrajoli; Sima Jeha; Hagop M Kantarjian
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

4.  Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.

Authors:  Theo D Kim; Seval Türkmen; Michaela Schwarz; Gökben Koca; Hendrik Nogai; Christiane Bommer; Bernd Dörken; Peter Daniel; Philipp le Coutre
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.